Arena Pharmaceuticals Inc (NASDAQ:ARNA)

65.25
BATS BZX Real-Time Price
As of 12:17pm ET
 +0.90 / +1.40%
Today’s Change
32.95
Today|||52-Week Range
69.75
+43.66%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$3.5B

Company Description

Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protien-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in San Diego, CA.

Contact Information

Arena Pharmaceuticals, Inc.
6154 Nancy Ridge Drive
San Diego California 92121-9604
P:(858) 453-7200
Investor Relations:

Employees

Shareholders

Mutual fund holders47.56%
Other institutional34.19%
Individual stakeholders0.22%

Top Executives

Amit Dilip MunshiPresident, Chief Executive Officer & Director
Laurie D. StelzerChief Financial Officer & Executive Vice President
Christopher H. CabellChief Medical Officer, Head-Research & Development
Douglas A. BakanVice President-Technical Operations
Vincent E. AurentzChief Business Officer & Executive Vice President